Literature DB >> 7054325

Prediction of tracheobronchial colonization in current cigarette smokers with chronic obstructive bronchitis.

R S Irwin, A D Erickson, M R Pratter, W M Corrao, F L Garrity, J R Myers, J T Kaemmerlen.   

Abstract

To help in clarifying the conflicting data on the role of tracheobronchial microflora in chronic bronchitis, the tracheobronchial microflora of a homogeneous group of clinically stable patients with chronic obstructive bronchitis was characterized by transtracheal aspiration. Their mean percentage ratio of forced expiratory volume in 1 sec to the forced vital capacity was 45%. The results were that (1) a bacterial tracheobronchial microflora was present in only 50% of the patients, (2) viridans streptococci were the bacteria most frequently isolated, and (3) the presence or absence of a tracheobronchial microflora was significantly associated with the amount of present cigarette smoking. The fact that patients who smoke less than one pack per day were most likely to have a sterile tracheobronchial tree (P=0.015) implied that there was a critical amount of cigarette smoke that impaired the clearance and/or detoxification of bacteria from the tracheobronchial tree and that it must have been persistently present.

Entities:  

Mesh:

Year:  1982        PMID: 7054325     DOI: 10.1093/infdis/145.2.234

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  [Smoking and lower respiratory tract infection].

Authors:  R B Brown
Journal:  Infection       Date:  1987       Impact factor: 3.553

2.  Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy.

Authors:  H M Pollock; E L Hawkins; J R Bonner; T Sparkman; J B Bass
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

Review 3.  Interventions to prevent chronic obstructive pulmonary disease exacerbations.

Authors:  Dennis E Niewoehner
Journal:  Am J Med       Date:  2004-12-20       Impact factor: 4.965

Review 4.  Chronic obstructive pulmonary disease.

Authors:  J M Madison; R S Irwin
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.